Humoral and T cell Responses to SARS-CoV-2 Vaccine Booster and Anti-SARS-CoV-2 Monoclonal Antibodies in Patients With End-Stage Kidney Disease
Kidney Int Rep
.
2023 Apr 29;8(7):1473-1475.
doi: 10.1016/j.ekir.2023.04.026.
Online ahead of print.
Authors
Gianluigi Zaza
1
,
Giovanni Stallone
1
,
Simona Granata
1
,
Micaela Gentile
2
,
Maddalena Panico
1
,
Sofia Bin
2
3
4
,
Lin Wang
5
,
Christiane Rollenhagen
6
,
Jonathan S Maltzman
6
7
,
Paolo Cravedi
2
Affiliations
1
Nephrology, Dialysis and Transplantation Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
2
Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
3
IRCCS Azienda Ospedaliero-Universitaria di Bologna, UO di Nefrologia Dialisi e Trapianto, Italy.
4
CIRI Scienze della Vita e Tecnologie per la Salute - Alma Mater Studiorum Università di Bologna, Italy.
5
Stanford Blood Center, Histocompatibility and Immunogenetics Laboratory, Palo Alto, California, USA.
6
Geriatric Research Education and Clinical Center, VA Palo Alto Health Care System, Palo Alto, California, USA.
7
Department of Medicine, Division of Nephrology, Stanford University School of Medicine, Palo Alto, California, USA.
PMID:
37360818
PMCID:
PMC10148717
DOI:
10.1016/j.ekir.2023.04.026
No abstract available